We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,728.50
Bid: 1,727.00
Ask: 1,728.00
Change: 23.50 (1.38%)
Spread: 1.00 (0.058%)
Open: 1,705.00
High: 1,729.50
Low: 1,695.50
Prev. Close: 1,705.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

US STOCKS-Wall St flat after retail sales, Nasdaq edges higher

Mon, 13th May 2013 16:41

* Core U.S. retail sales rise 0.5 percent in April

* Yum Brands falls as monthly Chinese sales drop

* Crude oil falls, pressuring energy companies

* Indexes: Dow down 0.2 pct, S&P up 0.1 pct, Nasdaq up 0.3pct

By Ryan Vlastelica

NEW YORK, May 13 (Reuters) - U.S. stocks were mostly flat onMonday as investors paused following a rally that took indexesto record highs, though a strong read on retail sales limiteddeclines and the Nasdaq ticked up on a rally in Netflix.

The S&P 500 has jumped more than 14 percent so far thisyear, a rally that has repeatedly taken it to record intradayand closing highs without sustained declines. While thelong-term trend is still viewed as positive, many analysts saidthe momentum could wane in the absence of positive catalysts.

Retail sales rose 0.1 percent in April, better than the 0.3percent drop that had been expected, and returning to growthfollowing a decline in March.

Excluding autos, gasoline and building materials, core salesrose 0.5 percent. Retail sales account for about 30 percent ofU.S. consumer spending.

"Recent data has been weak, so to see some sturdiness isimportant and needed in order for us to move materially higher,"said Mark Luschini, chief investment strategist at JanneyMontgomery Scott in Philadelphia. "But given the strength we'vehad over the past few weeks, it isn't surprising that trading isa bit indifferent today."

The S&P 500 managed its third straight weekly gainlast week, reaching a record high on Friday. The benchmark had a five-day streak of record closing highs before settling loweron Thursday.

The Dow Jones industrial average was down 24.04points, or 0.16 percent, at 15,094.45. The Standard & Poor's 500Index was up 1.41 points, or 0.09 percent, at 1,635.11.The Nasdaq Composite Index was up 8.40 points, or 0.24percent, at 3,444.99.

Netflix Inc jumped 4.2 percent to $226.81 as one ofthe biggest advancing stocks in the S&P 500, helping to keep theNasdaq in slightly positive territory.

Other data showed business inventories were unchanged inMarch for a second straight month versus expectations of 0.3percent rise, suggesting restocking could help second-quartereconomic growth.

Crude oil fell 0.7 percent to $95.39 per barrel,pressured by a drop to an eight-month low in demand in China.

Luschini, who helps oversee $58 billion in assets, said thedrop in oil and gasoline prices contributed to the strong readon retail sales, "so it is helpful to see those remain tame.

"However, if we dip below $90 a barrel, that will hurt theenergy sector and could be a signal of lower global growth."

Consol Energy fell 2 percent to $34.14 whileNational Oilwell Varco was off 1.4 percent at $67.27.

Yum Brands Inc fell 2.6 percent to $68.54. After themarket closed on Friday, the fast food chain operator posted asteep decline in Chinese April sales.

With 90 percent of the S&P 500 having reported, 67.2 percentof companies have topped earnings expectations, according toThomson Reuters data, an amount that is even with the averageover the past four quarters. Only 46.9 percent have beatenrevenue expectations, under the 52 percent average over the pastfour quarters.

Elan agreed to a $1 billion deal to buy 21percent of the royalties that U.S. company Theravance receives from GlaxoSmithKline for itsrespiratory drugs. Theravance shares jumped 15 percent to$40.33.

U.S.-listed shares of Perion Network surged 12percent to $14.10 after the Israeli consumer Internet companyposted first-quarter earnings.

SoftBank Corp has told banks that their financingof Dish Network Corp's $25.5 billion rival offer forSprint Nextel Corp could hurt their chances of landing arole in a highly anticipated public offering of Chinesee-commerce giant Alibaba Group Holding Ltd, two sources familiarwith the situation said.

Sprint shares dipped 1.6 percent to $7.24 while Dish lost1.7 percent to $38.51.

More News
16 Jan 2024 17:04

GSK to sell GBP1 billion worth of Haleon shares as trims stake again

(Alliance News) - GSK PLC on Tuesday said it intends to sell around GBP1.00 billion worth of shares in Haleon PLC, as it continues to reduce its shareholding in the Weybridge, Surrey-based consumer healthcare spin-off.

Read more
16 Jan 2024 09:14

LONDON BROKER RATINGS: UBS raises GSK and cuts AstraZeneca

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
16 Jan 2024 08:15

UBS downgrades AstraZeneca to 'sell'

(Sharecast News) - UBS has downgraded AstraZeneca and upgraded rival GSK as part of its latest review of the European pharmaceutical sector.

Read more
16 Jan 2024 07:37

LONDON BRIEFING: UK jobless rate sticks at 4.2% but pay growth slows

(Alliance News) - Stocks in London are called to open lower on Tuesday, following data showing that the UK jobless rate was unchanged at 4.2% as pay growth slowed.

Read more
15 Jan 2024 08:42

Zantac fallout unfairly weighing on GSK, says Shore Capital

(Sharecast News) - Shore Capital has raised its target price and maintained a positive stance on biopharma giant GSK, saying that worries about the potential cost of Zantac litigation are unfairly weighing on the stock.

Read more
10 Jan 2024 09:35

LONDON BROKER RATINGS: BofA cuts Ashtead; UBS likes 3i Group

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
10 Jan 2024 08:25

GSK says Nucala gets green light in China for asthma treatment

(Alliance News) - GSK PLC on Wednesday said Nucala has been approved in China for the treatment of severe asthma.

Read more
10 Jan 2024 07:22

GSK's Nucala gets fresh approval in China

(Sharecast News) - GSK announced on Wednesday that the China National Medical Products Administration (NMPA) has granted approval for 'Nucala', or mepolizumab, as an add-on maintenance treatment for severe eosinophilic asthma in adults and adolescents aged 12 years and older.

Read more
9 Jan 2024 16:22

London close: Stocks finish red after choppy session

(Sharecast News) - London stocks had turned back into the red by the close on Tuesday, with recruitment firms and asset managers pacing the declines after some disappointing corporate updates.

Read more
9 Jan 2024 08:03

TOP NEWS: GSK to buy Aiolos Bio for up to USD1.4 billion

(Alliance News) - GSK PLC on Tuesday said it will acquire asthma drug developer Aiolos Bio Inc for USD1 billion upfront, as well as up to USD400 million in certain success-based milestone payments.

Read more
9 Jan 2024 07:16

GSK buys respiratory drug maker Aiolos for $1bn

(Sharecast News) - GSK said it was buying Aiolos, a clinical-stage biopharmaceutical company focused on treatment of respiratory and inflammatory conditions, for up to $1.4bn (£1.1bn).

Read more
8 Jan 2024 23:39

Pfizer to remain aggressive on obesity market after setback

NEW YORK, Jan 8 (Reuters) - Pfizer will remain aggressive in trying to break into the lucrative obesity market, even after dropping a high profile weight-loss drug candidate late last year due to strong side effects, Chief Executive Albert Bourla said on Monday.

Read more
8 Jan 2024 23:00

Pfizer to remain aggressive on obesity market after setback

NEW YORK, Jan 8 (Reuters) - Pfizer will remain aggressive in trying to break into the lucrative obesity market, even after dropping a high profile weight-loss drug candidate late last year due to strong side effects, Chief Executive Albert Bourla said on Monday.

Read more
8 Jan 2024 19:02

Moderna says it hit its 2023 COVID vaccine sales goal

Jan 8 (Reuters) - Moderna on Monday said its 2023 COVID vaccine sales would be around $6.7 billion, coming in above the lower end of its full-year forecast, and reiterated its goal of returning to sales growth in 2025.

Read more
4 Jan 2024 14:01

UK dividends calendar - next 7 days

Friday 5 January 
British Land Co PLCdividend payment date
Hill & Smith PLCdividend payment date
JD Sports Fashion PLCdividend payment date
JPMorgan Global Growth & Income PLCdividend payment date
Liontrust Asset Management PLCdividend payment date
Lok'n Store Group PLCdividend payment date
Real Estate Credit Investments Ltddividend payment date
RS Group PLCdividend payment date
Tate & Lyle PLCdividend payment date
Monday 8 January 
abrdn Equity Income Trust PLCdividend payment date
Intermediate Capital Group PLCdividend payment date
Tuesday 9 January 
no events scheduled 
Wednesday 10 January 
Assura PLCdividend payment date
Bellway PLCdividend payment date
Fidelity Special Values PLCdividend payment date
LXi REIT PLCdividend payment date
Severn Trent PLCdividend payment date
Volex PLCdividend payment date
Vp PLCdividend payment date
Thursday 11 January 
AJ Bell PLCex-dividend payment date
Ashtead Group PLCex-dividend payment date
BlackRock Latin American Investment Trust PLCex-dividend payment date
CMC Markets PLCdividend payment date
dotdigital Group PLCex-dividend payment date
Ecora Resources PLCex-dividend payment date
European Assets Trust PLCex-dividend payment date
Foresight Group Holdings Ltdex-dividend payment date
GSK PLCdividend payment date
ICG-Longbow Senior Secured UK Property Debt Investments Ltdex-dividend payment date
JPMorgan Asia Growth & Income PLCex-dividend payment date
Keystone Positive Change Investment Trust PLCex-dividend payment date
LondonMetric Property PLCdividend payment date
Murray International Trust PLCex-dividend payment date
National Grid PLCdividend payment date
Primary Health Properties PLCex-dividend payment date
Sage Group PLCex-dividend payment date
Smiths News PLCex-dividend payment date
SSE PLCex-dividend payment date
Supermarket Income REIT PLCex-dividend payment date
TR Property Investment Trust PLCdividend payment date
Walker Crips Group PLCex-dividend payment date
WH Smith PLCex-dividend payment date
Worldwide Healthcare Trust PLCdividend payment date
XPS Pensions Group PLCex-dividend payment date
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.